Aktis Oncology to Present at the Jefferies Global Healthcare Conference
Aktis Oncology, a clinical-stage company specializing in targeted radiopharmaceuticals, announced that CEO Matthew Roden will present at the Jefferies Global Healthcare Conference showcasing the company's proprietary miniprotein radioconjugate platform and clinical pipeline. Aktis aims to develop innovative cancer treatments targeting multiple soli…